Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell

Journal of Virology

Volumn 71, Issue 7, 1997, Pages 4882-4891

  Miyashita, Emily M ^a   Yang, Bin ^a   Babcock, Gregory J ^a   Thorley Lawson, David A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B LYMPHOCYTE; CELL CYCLE; EPSTEIN BARR VIRUS; IMMUNOSURVEILLANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0031007613     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.7.4882-4891.1997     Document Type: Article

References (36)

1. Anagnostopoulos, I., M. Hummel, C. Kreschel, and H. Stein. 1995. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 85:744-750.
2. Azuma, M., M. Cayabyab, D. Buck, J. H. Phillips, and L. L. Lanier. 1992. CD28 interaction with B7 costimulates primary allogencic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J. Exp. Med. 175:353-360.
3. Chen, F., J.-Z. Zou, L. di Renzo, G. Winberg, L.-F. Hu, E. Klein, G. Klein, and I. Ernberg. 1995. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J. Virol. 69:3752-3758.
4. Decker, L. L., L. D. Klaman, and D. A. Thorley-Lawson. 1996. Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J. Virol. 70:3286-3289.
5. Gerdes, J., H. Lemke, H. Baisch, H. H. Wacker, U. Schwab, and H. Stein. 1984. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133:1710-1715.
6. Gregory, C. D., T. Tursz, C. F. Edwards, C. Tetaud, M. Talbot, B. Caillou, A. B. Rickinson, and M. Lipinski. 1987. Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype. J. Immunol. 139: 313-318.
7. Hall, K. T., L. Boumsell, J. L. Schultze, V. A. Boussiotis, D. M. Dorfman, A. A. Cardoso, A. Bensussan, L. M. Nadler, and G. Freeman. 1996. Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc. Natl. Acad. Sci. USA 93:11780-11785.
8. Huang, A. Y., P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll, and H. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264:961-965.
9. Hurley, E. A., and D. A. Thorley-Lawson. 1988. B cell activation and the establishment of Epstein-Barr virus latency. J. Exp. Med. 168:2059-2075.
10. Jacob, M. C., M. Favre, and J. C. Bensa. 1991. Membrane cell permeabilization with saponin and multiparametric analysis by flow cytometry. Cytometry 12:550-558.
11. Karajannis, M. A., M. Hummel, I. Anagnostopoulos, and H. Stein. 1997. Strict lymphotropism of Epstein-Barr virus during acute infectious mononucleosis in non-immunocompromised individuals. Blood 89:2856-2862.
12. Khan, G., E. M. Miyashita, B. Yang, G. J. Babcock, and D. A. Thorley-Lawson. 1996. Is EBV persistence in vivo a model for B cell homeostasis? Immunity 5:173-179.
13. Kieff, E. 1996. Epstein-Barr virus and its replication, p. 2343-2396. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology, 3rd ed., vol. 2. Raven Press, New York, N.Y.
14. Klein, G. 1994. Epstein-Barr virus strategy in normal and neoplastic B-cells. Cell 77:791-793.
15. Levitskaya, J., M. Coram, V. Levitsky, S. Imreh, M. P. Steigerwald, G. Klein, M. G. Kurilla, and M. G. Masucci. 1995. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685-688.
16. Lewin, N., P. Aman, M. G. Masucci, E. Klein, G. Klein, B. Oberg, H. Strander, W. Henle, and G. Henle. 1987. Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth. Int. J. Cancer 39:472-476.
17. Masucci, M. G., and I. Ernberg. 1994. Epstein-Barr virus: adaptation to a life within the immune system. Trends Microbiol. 2:125-130.
18. Miller, C. L., A. L. Burkhardt, J. H. Lee, B. Stealey, R. Longnecker, J. B. Bolen, and E. Kieff. 1995. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2:155-166.
19. Miyashita, E., and D. A. Thorley-Lawson. 1995. A new form of Epstein-Barr virus latency in vivo. Curr. Top. Microbiol. Immunol. 194:135-144.
20. Miyashita, E. M., B. Yang, K. M. Lam, D. H. Crawford, and D. A. Thorley-Lawson. 1995. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80:593-601.
21. Qu, L., and D. T. Rowe. 1992. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J. Virol. 66:3715-3724.
22. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus, p. 2397-2446. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology, 3rd ed., vol. 2. Raven Press, New York, N.Y.
23. Rickinson, A. B., Q. Y. Yao, and L. E. Wallace. 1985. The Epstein-Barr virus as a model of virus-host interactions. Br. Med. Bull. 41:75-79.
24. Robinson, J., D. Smith, and J. Niederman. 1980. Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis. Nature 287:334-335.
25. Rowe, M., D. T. Rowe, C. D. Gregory, L. S. Young, P. J. Farrell, H. Rupani, and A. B. Rickinson. 1987. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J. 6:2743-2751.
26. 25a. Sample, J. Personal communication.
27. Stout, R. D., and J. Suttles. 1992. T cells bearing the CD44hi "memory" phenotype display characteristics of activated cells in G1 stage of cell cycle. Cell. Immunol. 141:433-443.
28. Tao, Q., G. Srivastava, A. C. Chan, L. P. Chung, S. L. Loke, and F. C. Ho. 1995. Evidence for lytic infection by Epstein-Barr virus in mucosal lymphocytes instead of nasopharyngeal epithelial cells in normal individuals. J. Med. Virol. 45:71-77.
29. Tao, Q., G. Srivastava, A. C. Chan, and F. C. Ho. 1995. Epstein-Barr-virus-infected nasopharyngeal intraepithelial lymphocytes. Lancet 345:1309-1310.
30. Thorley-Lawson, D. A. 1989. Immunological responses to Epstein-Barr virus infection and the pathogenesis of EBV-induced diseases. Biochim. Biophys. Acta 948:263-286.
31. Thorley-Lawson, D. A., and K. P. Mann. 1985. Early events in Epstein-Barr virus infection provide a model for B cell activation. J. Exp. Med. 162:45-59.
32. Thorley-Lawson, D. A., E. M. Miyashita, and G. Khan. 1996. Epstein-Barr virus and the B cell: that's all it takes. Trends Microbiol. 4:204-208.
33. Tierney, R. J., N. Steven, L. S. Young, and A. B. Rickinson. 1994. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68:7374-7385.
34. Wu, T. C., A. Y. Huang, E. M. Jaffee, H. I. Levitsky, and D. M. Pardoll. 1995. A reassessment of the role of B7-1 expression in tumor rejection. J. Exp. Med. 182:1415-1421.
35. Yao, Q. Y., H. Czarnecka, and A. B. Rickinson. 1991. Spontaneous outgrowth of Epstein-Barr virus-positive B-cell lines from circulating human B cells of different buoyant densities. Int. J. Cancer 48:253-257.
36. Yates, J. L., N. Warren, and B. Sugden. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313: 812-815.